약제 용출 스텐트 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년에는 113억 7,000만 달러에 달할 것으로 예상되며, 연평균 8.2%의 성장률을 보일 것으로 예상됩니다. 예측 기간의 성장은 인구 고령화 및 만성질환 부담, 적응증 확대, 의료비 상환 정책, 세계 시장 확대, 환자 중심 치료 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 맞춤형 의료, 저침습적 기술, 신흥 헬스케어 기술, 차세대 제제 등을 들 수 있습니다.
수질 오염 수준 증가는 향후 수년간 생태독성 테스트 시장의 성장을 가속할 것으로 예상됩니다. 수질 오염은 강, 호수, 호수, 해양, 지하수 등의 수역이 유해한 오염 물질에 의해 오염되어 인간의 건강, 수생 생물 및 환경에 악영향을 미치는 것을 말합니다. 오염 증가는 산업 폐수, 비료와 농약을 포함한 농업 폐수, 부적절한 폐기물 처리, 하수 오염을 유발하는 도시화, 오일 유출 등의 요인에 의해 발생합니다. 생태독성학 연구는 화학물질, 중금속 등 오염물질이 수생 생물에 미치는 독성을 평가하고 수질 오염의 유해한 영향을 줄이기 위한 오염 방지 전략을 개발하는 데 도움이 됩니다. 예를 들어 2024년 8월 버킹엄 퓨처스(Buckingham Futures)가 발표한 자료에 따르면 영국의 하천과 해역의 하수 유출 시간은 2022년 175만 시간에 달했고, 2023년에는 360만 시간으로 증가했습니다. 이에 따라 수질 오염이 증가하면서 생태독성학 연구에 대한 수요가 증가하고 있습니다.
약제 용출 스텐트 시장에서 활동하는 기업은 환자의 예후를 개선하고 중재적 심장병 치료를 발전시키기 위해 이중층 풍선과 같은 혁신적인 약물전달 시스템을 개발하는 데 주력하고 있습니다. 약제 용출 스텐트 시스템내 이중층 풍선은 동맥벽에 약물을 균일하게 도포하고 제어할 수 있으며, 약물전달 및 스텐트 삽입의 정확도를 향상시킵니다. 예를 들어 2022년 8월 Medtronic Plc는 이전 세대 Resolute Onyx DES의 급성기 성능과 임상 데이터를 기반으로 약물전달 시스템을 강화하도록 설계된 최신 세대 약제 용출 관상동맥 스텐트 시스템인 Onyx Frontier를 발표했습니다. Onyx Frontier DES는 Resolute Onyx와 동일한 고품질 스텐트 플랫폼을 사용하며, 직경 2.0mm에서 5.0mm까지 다양한 크기의 환자를 치료할 수 있는 것이 특징입니다. 획기적인 2중 구조의 풍선, 크로스 프로파일 축소, 카테터 유연성 향상 등 주목할 만한 디자인 개선으로 이전 세대의 Resolute Onyx DES에 비해 직경 강도를 유지하면서 전달 능력을 16% 향상시켰습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 약제 용출 스텐트 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 용도 산업의 분석
- 세계의 약제 용출 스텐트 시장 : 성장률 분석
- 세계의 약제 용출 스텐트 시장 실적 : 규모와 성장, 2019-2024
- 세계의 약제 용출 스텐트 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 약제 용출 스텐트 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 약제 용출 스텐트 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 폴리머 기반
- 폴리머 프리
- 세계의 약제 용출 스텐트 시장 : 약물별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Sirolimus
- Paclitaxel
- Zotarolimus
- Everolimus
- Biolimus
- 기타 약물
- 세계의 약제 용출 스텐트 시장 : 스캐폴드별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 코발트 크롬
- 플래티넘 크롬
- 니티놀
- 생분해성
- 기타 스캐폴드
- 세계의 약제 용출 스텐트 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 관상동맥 질환
- 말초혈관 질환
- 세계의 약제 용출 스텐트 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 전문 클리닉
- 세계의 약제 용출 스텐트 시장, 폴리머 기반의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 내구성 폴리머 약제 용출 스텐트
- 생분해성 폴리머 약제 용출 스텐트
- 세계의 약제 용출 스텐트 시장, 폴리머 프리의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 약제 코팅 베어메탈 스텐트
- 기타 폴리머 프리 약제 용출 스텐트
제7장 지역별·국가별 분석
- 세계의 약제 용출 스텐트 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 약제 용출 스텐트 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 약제 용출 스텐트 시장 : 경쟁 구도
- 약제 용출 스텐트 시장 : 기업 개요
- Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- Abbott Overview, Products and Services, Strategy and Financial Analysis
- Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- InspireMD Inc.
- B. Braun Melsungen AG
- Cook Group Incorporated
- Lepu Medical Technology(Beijing) Co. Ltd.
- Biotronik
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
- Biosensors International Group Ltd.
- OrbusNeich Medical Company Limited
- Alvimedica Medical Technologies
- Hexacath
- Elixir Medical Corporation
- Translumina GmbH
- Cardionovum GmbH
- QualiMed Innovative Medizinprodukte GmbH
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 약제 용출 스텐트 시장 2029 : 새로운 기회를 제공하는 국가
- 약제 용출 스텐트 시장 2029 : 새로운 기회를 제공하는 부문
- 약제 용출 스텐트 시장 2029 : 성장 전략
제36장 부록
KSA
A drug-eluting stent (DES) is a medical device employed in the treatment of coronary artery disease (CAD). It constitutes a small, mesh-like tube typically constructed from metal, which is inserted into narrowed or blocked coronary arteries during a procedure known as percutaneous coronary intervention (PCI) or angioplasty.
The primary product types of drug-eluting stents include polymer-based and polymer-free varieties. Polymer-based drug-eluting stents (DES) are stents coated with a thin polymer layer that encapsulates the drug(s) intended for delivery to the arterial wall. These drugs may include sirolimus, paclitaxel, zotarolimus, everolimus, biolimus, among others, with scaffolds such as cobalt-chromium, platinum-chromium, nitinol, biodegradable materials, and others. They find application in coronary diseases and peripheral vascular disease and are utilized by end-users such as hospitals and specialty clinics.
The drug eluting stent market research report is one of a series of new reports from The Business Research Company that provides drug eluting stent market statistics, including drug eluting stent industry global market size, regional shares, competitors with a drug eluting stent market share, detailed drug eluting stent market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting stent industry. This drug eluting stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The drug eluting stent market size has grown strongly in recent years. It will grow from $7.63 billion in 2024 to $8.29 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to the need for improved treatment options, clinical evidence, regulatory approval, healthcare economics, and guidelines and recommendations.
The drug eluting stent market size is expected to see strong growth in the next few years. It will grow to $11.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to an aging population and chronic disease burden, the expansion of indications, healthcare reimbursement policies, global market expansion, and patient-centered care. Major trends in the forecast period include personalized medicine, minimally invasive techniques, emerging healthcare technologies, and next-generation drug formulations.
The rising levels of water pollution are expected to drive the growth of the ecotoxicological studies market in the coming years. Water pollution refers to the contamination of water bodies, such as rivers, lakes, oceans, and groundwater, by harmful pollutants, which negatively impact human health, aquatic life, and the environment. The increasing pollution is driven by factors like industrial discharges, agricultural runoff containing fertilizers and pesticides, improper waste disposal, urbanization causing sewage contamination, and oil spills. Ecotoxicological studies assess the toxicity of pollutants, such as chemicals, heavy metals, and other contaminants, on aquatic organisms, helping to develop pollution control strategies to reduce the harmful effects of water pollution. For example, data from Buckingham Futures in August 2024 reported that sewage spills in England's rivers and seas totaled 1.75 million hours in 2022, which increased to 3.6 million hours in 2023. As a result, the growing water pollution is fueling the demand for ecotoxicological studies.
Companies operating in the drug-eluting stent market are directing their efforts toward developing innovative delivery systems, such as the dual-layer balloon, to enhance patient outcomes and advance interventional cardiology. A dual-layer balloon within a drug-eluting stent system improves precision in drug delivery and stent deployment by offering better control and uniform drug application to the arterial wall. For instance, in August 2022, Medtronic Plc introduced Onyx Frontier, the latest generation of drug-eluting coronary stent systems designed to enhance delivery systems, building upon the acute performance and clinical data from the previous Resolute Onyx DES generation. The Onyx Frontier DES utilizes the same high-quality stent platform as Resolute Onyx and features a wide size range to treat patients with diameters ranging from 2.0mm to 5.0mm. Notable design enhancements include a groundbreaking dual-layer balloon, reduced crossing profile, and enhanced catheter flexibility, resulting in a 16% increase in deliverability compared to the previous Resolute Onyx DES generation, while maintaining radial strength.
In October 2023, Cordis acquired MedAlliance for an undisclosed sum. This acquisition is aimed at furthering Cordis' tradition of cardiovascular innovation and expanding its product portfolio in the coronary and peripheral vascular markets. MedAlliance is a Switzerland-based medical device manufacturer and distributor specializing in drug-eluting stents.
Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.
North America was the largest region in the drug-eluting stent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the drug eluting stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The drug eluting stent market consists of revenues earned by entities by providing services such as pre-procedural assessment, procedural intervention, intraoperative monitoring, post-procedural care, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug eluting stenting market also includes sales of products including guide wires, angioplasty equipment, intravascular imaging systems, hemostasis devices, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Drug Eluting Stent Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on drug eluting stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for drug eluting stent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug eluting stent market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Polymer-Based; Polymer-Free
- 2) By Drug: Sirolimus; Paclitaxel; Zotarolimus; Everolimus; Biolimus; Other Drugs
- 3) By Scaffold: Cobalt-Chromium; Platinum-Chromium; Nitinol; Biodegradable; Other Scaffolds
- 4) By Application: Coronary Diseases; Peripheral Vascular Diseases
- 5) By End-User: Hospitals; Specialty Clinic
- Subsegments:
- 1) By Polymer-Based: Durable Polymer Drug-Eluting Stents; Biodegradable Polymer Drug-Eluting Stents
- 2) By Polymer-Free: Bare-Metal Stents With Drug Coating; Other Polymer-Free Drug-Eluting Stents
- Companies Mentioned: Johnson & Johnson Services Inc.; Abbott; Medtronic plc; Boston Scientific Corporation; Terumo Corporation
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Drug Eluting Stent Market Characteristics
3. Drug Eluting Stent Market Trends And Strategies
4. Drug Eluting Stent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Drug Eluting Stent Growth Analysis And Strategic Analysis Framework
- 5.1. Global Drug Eluting Stent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Drug Eluting Stent Market Growth Rate Analysis
- 5.4. Global Drug Eluting Stent Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Drug Eluting Stent Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Drug Eluting Stent Total Addressable Market (TAM)
6. Drug Eluting Stent Market Segmentation
- 6.1. Global Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polymer-Based
- Polymer-Free
- 6.2. Global Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sirolimus
- Paclitaxel
- Zotarolimus
- Everolimus
- Biolimus
- Other Drugs
- 6.3. Global Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cobalt-Chromium
- Platinum-Chromium
- Nitinol
- Biodegradable
- Other Scaffolds
- 6.4. Global Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Coronary Diseases
- Peripheral Vascular Diseases
- 6.5. Global Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinic
- 6.6. Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Durable Polymer Drug-Eluting Stents
- Biodegradable Polymer Drug-Eluting Stents
- 6.7. Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Free, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bare-Metal Stents With Drug Coating
- Other Polymer-Free Drug-Eluting Stents
7. Drug Eluting Stent Market Regional And Country Analysis
- 7.1. Global Drug Eluting Stent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Drug Eluting Stent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Drug Eluting Stent Market
- 8.1. Asia-Pacific Drug Eluting Stent Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Drug Eluting Stent Market
- 9.1. China Drug Eluting Stent Market Overview
- 9.2. China Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Drug Eluting Stent Market
- 10.1. India Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Drug Eluting Stent Market
- 11.1. Japan Drug Eluting Stent Market Overview
- 11.2. Japan Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Drug Eluting Stent Market
- 12.1. Australia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Drug Eluting Stent Market
- 13.1. Indonesia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Drug Eluting Stent Market
- 14.1. South Korea Drug Eluting Stent Market Overview
- 14.2. South Korea Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Drug Eluting Stent Market
- 15.1. Western Europe Drug Eluting Stent Market Overview
- 15.2. Western Europe Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Drug Eluting Stent Market
- 16.1. UK Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Drug Eluting Stent Market
- 17.1. Germany Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Drug Eluting Stent Market
- 18.1. France Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Drug Eluting Stent Market
- 19.1. Italy Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Drug Eluting Stent Market
- 20.1. Spain Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Drug Eluting Stent Market
- 21.1. Eastern Europe Drug Eluting Stent Market Overview
- 21.2. Eastern Europe Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Drug Eluting Stent Market
- 22.1. Russia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Drug Eluting Stent Market
- 23.1. North America Drug Eluting Stent Market Overview
- 23.2. North America Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Drug Eluting Stent Market
- 24.1. USA Drug Eluting Stent Market Overview
- 24.2. USA Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Drug Eluting Stent Market
- 25.1. Canada Drug Eluting Stent Market Overview
- 25.2. Canada Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Drug Eluting Stent Market
- 26.1. South America Drug Eluting Stent Market Overview
- 26.2. South America Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Drug Eluting Stent Market
- 27.1. Brazil Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Drug Eluting Stent Market
- 28.1. Middle East Drug Eluting Stent Market Overview
- 28.2. Middle East Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Drug Eluting Stent Market
- 29.1. Africa Drug Eluting Stent Market Overview
- 29.2. Africa Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Drug Eluting Stent Market Competitive Landscape And Company Profiles
- 30.1. Drug Eluting Stent Market Competitive Landscape
- 30.2. Drug Eluting Stent Market Company Profiles
- 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
31. Drug Eluting Stent Market Other Major And Innovative Companies
- 31.1. InspireMD Inc.
- 31.2. B. Braun Melsungen AG
- 31.3. Cook Group Incorporated
- 31.4. Lepu Medical Technology (Beijing) Co. Ltd.
- 31.5. Biotronik
- 31.6. Meril Life Sciences Pvt. Ltd.
- 31.7. MicroPort Scientific Corporation
- 31.8. Biosensors International Group Ltd.
- 31.9. OrbusNeich Medical Company Limited
- 31.10. Alvimedica Medical Technologies
- 31.11. Hexacath
- 31.12. Elixir Medical Corporation
- 31.13. Translumina GmbH
- 31.14. Cardionovum GmbH
- 31.15. QualiMed Innovative Medizinprodukte GmbH
32. Global Drug Eluting Stent Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Drug Eluting Stent Market
34. Recent Developments In The Drug Eluting Stent Market
35. Drug Eluting Stent Market High Potential Countries, Segments and Strategies
- 35.1 Drug Eluting Stent Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Drug Eluting Stent Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Drug Eluting Stent Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
